Who is sponsoring NCT06249776?

NCT06249776 is sponsored by Gravity Medical Technology, INC.

What drugs are being tested in NCT06249776?

Interventions in NCT06249776: Supernova revascularization device.

What condition does NCT06249776 study?

NCT06249776 studies Ischemic Stroke, Stroke, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Vascular Diseases, Cardiovascular Diseases.

Is NCT06249776 still recruiting?

NCT06249776 is currently completed. Last updated 17 April 2026.

Last reviewed 2026-04-17 · How we verify

NCT06249776: GRASSROOT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial

Completed NA Last updated 17 April 2026

What this trial tests

NA trial testing Supernova revascularization device in Ischemic Stroke in 54 participants. Completed in 14 April 2026.

Timeline

9 February 2024

Primary endpoint
14 April 2026

14 April 2026

Quick facts

Lead sponsor	Gravity Medical Technology, INC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	54
Start date	9 February 2024
Primary completion	14 April 2026
Estimated completion	14 April 2026
Sites	11 locations across Pakistan, Iran, India

Drugs / interventions tested

Supernova revascularization device

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →
Stroke — all drugs for Stroke →
Cerebrovascular Disorders — all drugs for Cerebrovascular Disorders →
Brain Diseases — all drugs for Brain Diseases →

Sponsor

Gravity Medical Technology, INC

Who can join

Adults 18 to 85, any sex, with Ischemic Stroke or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the safety and efficacy of the Supernova stent retriever device, developed by Gravity Medical Technology, for treating acute ischemic stroke. The device is used to remove blood clots and restore blood flow to the brain .

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mechanical thrombectomy for acute ischemic stroke in a low- and middle-income country: primary outcomes from the GRASSROOT Trial.
Yavagal DR, Gaikwad SB, Vibha D, Narayan SK, et al · · 2025 · PMID 41371775 · DOI 10.1136/jnis-2025-024470
Late break abstract - 2024
· 2024

Verify or expand the search:

Other trials of Supernova revascularization device

Trials testing the same drug.

NCT07335185 — Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes · NA · not yet recruiting

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Gravity Medical Technology, INC trials

Trials by the same sponsor.

NCT07335185 — Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06249776 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gravity Medical Technology, INC
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06249776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing